EIT Food
-
DATABASE (219)
-
ARTICLES (288)
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Oscillum: The intelligent label to reduce food waste
The Spanish biotech startup has developed sensors embedded in biodegradable plastic labels to monitor “product freshness” beyond expiration dates, helping consumers to avoid food waste and save money
Futuralga: Circular economy model to turn seaweed into biodegradable plastic alternative
A Cádiz-based young startup is winning accolades for its eco-friendly bioplastic made from seaweed washed ashore
SwissDeCode: Portable DNA test kits detect food contamination within minutes
DNAFoil, the startup’s rapid and accurate on-site food safety testing kit, can be deployed by non-expert staff after a few hours of training, with no need for lab equipment
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
Plant on Demand: Helping small-scale organic farmers to thrive, sustainably
Plant on Demand will soon deploy product PODX’s “prescriptive” analytics to boost organic farmers’ productivity and prices, by optimizing future crop yields to match seasonal sales trends
Plantruption: Transforming Irish seaweed into sustainable alt-protein seafood
Using abundant local seaweed as highly nutritious, eco-friendly alternatives to fish, the Dublin-based startup is gearing up to tap into new markets in Europe and the US
Feedect provides nutritional insect protein to feed the future
Feedect farms insects to produce high-quality protein alternatives for animal and human food
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
European agritech is the new global focus, as startup investments nearly doubled in 2019
Last year, European agritech surpassed China for the first time in investments received, with openings in multiple subsectors from big data to blockchain
Heura by Foods for Tomorrow: Another new kid on the multibillion-dollar alternative protein market
Already selling in nine countries, Heura’s recent entry into the UK, Europe's largest market for meat substitutes, could prove its biggest test to date
HumanITcare: The first real-time symptom tracker for mental illness patients
FollowHealth’s HumanITcare app combines wearables, analytics and AI to monitor and improve outcomes for sufferers of depression, schizophrenia, alcoholism and more
Solatom: Cost-effective flatpack mobile solar energy units for SMEs
Solatom's turnkey solar thermal solutions can cut energy costs by 37%. Its real-time data analytics can also be used to ensure that the industrial processing units are operating at optimal conditions
Verkor: Accelerating low‑carbon battery production in France
French startup Verkor aims to raise up to €1.3bn by the end of next year to finance its first Gigafactory producing sustainable lithium-ion batteries for the European market
HeartGenetics: Using genetic data and AI to improve predictive health outcomes
Amid growing demand for personalized health and wellness solutions, the Portuguese startup is seeking €2m to expand to Germany and the UK
Refurbed: Electronics recycling marketplace gets $54m for EU consolidation, overseas expansion
Consumers can reduce their carbon footprints by shifting toward a circular economy, become carbon-neutral by planting one tree with every purchase from Refurbed
Sorry, we couldn’t find any matches for “EIT Food”.
